The following table presents the computation of basic loss per share (in thousands, except per share amounts):



	Three Months Ended						Nine Months Ended
	March 25, 2018			March 26, 2017			March 25, 2018			March 26, 2017
Net loss		($240,577	)		($99,013	)		($246,712	)		($92,230	)
Weighted average common shares	100,140			97,346			99,046			98,791
Basic loss per share		($2.40	)		($1.02	)		($2.49	)		($0.93	)

The following computation reconciles the differences between the basic and diluted loss per share presentations (in thousands, except per share amounts):



	Three Months Ended						Nine Months Ended
	March 25, 2018			March 26, 2017			March 25, 2018			March 26, 2017
Net loss		($240,577	)		($99,013	)		($246,712	)		($92,230	)
Weighted average common shares - basic	100,140			97,346			99,046			98,791
Dilutive effect of stock options, nonvested shares and Employee Stock Purchase Plan purchase rights	—			—			—			—
Weighted average common shares - diluted	100,140			97,346			99,046			98,791
Diluted loss per share		($2.40	)		($1.02	)		($2.49	)		($0.93	)

Potential common shares that would have the effect of increasing diluted earnings per share or decreasing diluted loss per share are considered to be anti-dilutive and as such, these shares are not included in calculating diluted earnings per share. For the three and nine months ended March 25, 2018, there were 3.8 million and 4.4 million, respectively, of potential common shares not included in the calculation of diluted loss per share because their effect was anti-dilutive. For the three and nine months ended March 26, 2017, there were 11.3 million and 11.5 million, respectively, of potential common shares not included in the calculation of diluted loss per share because their effect was anti-dilutive.